, ritonavir) or discontinuation of the cytochrome P450 3A4 inducer such as rifampin, carbamazepine, and phenytoin, may possibly bring about a rise in codeine plasma concentrations with subsequently increased metabolism by cytochrome P450 2D6, resulting in higher morphine ranges, which could increase or extend adverse reactions and should result in https://legal-lean-for-sale01111.estate-blog.com/31550082/5-easy-facts-about-akorn-codeine-described